EUROpean clinical validation of a new ex vivo eXpanded stem cell theraPy for cArdiac regeNeration after acute myocarDial infarction: EUROXPAND

Project Information

EuroXpand

Grant agreement ID: 806595

DOI 10.3030/806595

Project closed

EC signature date 11 April 2018

Start date 1 May 2018

End date 31 December 2023

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 5 000 000,00

EU contribution € 5 000 000,00

Coordinated by

CELLPROTHERA
France

Deliverables

Documents, reports (2)

Press Release - Project kick-off
Communication material (brochures, web…)

To allow a wide dissemination of the presentation of EUROXPAND project, communication material (brochures, web…) will be realised.